Pain Therapeutic Injectables Market

Future Market Insights

Key Insight

The pain therapeutic injectables market is projected to grow from USD 21.1 billion in 2025 to USD 32.7 billion by 2035, at a CAGR of 4.5%. Opioids will dominate with a 42.7% market share, while otc products will lead the product segment with a 55.6% share.

September 19, 2025

Anurag Sharma

425 Pages

Cite this Report

Pain Therapeutic Injectables Market

https://www.futuremarketinsights.com/reports/pain-therapeutic-injectables-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Boehringer Ingelheim International GmbH
GSK plc
Novartis
The Vanguard Group
L'Oréal
Sun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Pain Therapeutic Injectables Market

Key Players

Similar Industry Reports